HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jakub Zolnierek Selected Research

Jakub Zolnierek Research Topics

Disease

4Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 01/2009
2Neoplasms (Cancer)
01/2021 - 01/2009
1Microsatellite Instability
12/2023
1Colorectal Neoplasms (Colorectal Cancer)
12/2023
1Carcinoma (Carcinomatosis)
09/2023
1Kidney Neoplasms (Kidney Cancer)
01/2021
1Disease Progression
11/2015
1Proteinuria
11/2015
1Myocardial Infarction
11/2015
1Hypertension (High Blood Pressure)
03/2014
1Clear-cell metastatic renal cell carcinoma
03/2014
1Fatigue
03/2014
1Melanoma (Melanoma, Malignant)
02/2013

Drug/Important Bio-Agent (IBA)

2pembrolizumabIBA
12/2023 - 09/2023
2lenvatinibIBA
09/2023 - 11/2015
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015 - 03/2014
2Sorafenib (BAY 43-9006)FDA Link
03/2014 - 01/2009
1Immune Checkpoint InhibitorsIBA
12/2023
1PlatinumIBA
09/2023
1Pyruvate KinaseIBA
01/2021
1Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2021
1Fructose-BisphosphataseIBA
01/2021
1EverolimusFDA Link
11/2015
1MTOR InhibitorsIBA
03/2014
14- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA
03/2014
1Phosphotransferases (Kinase)IBA
02/2013
1Immunomodulating AgentsIBA
02/2013
1Sunitinib (Sutent)FDA Link
01/2009
1Tyrosine Kinase InhibitorsIBA
01/2009

Therapy/Procedure

4Therapeutics
09/2023 - 01/2009
1Drug Therapy (Chemotherapy)
02/2013
1Immunotherapy
02/2013